Neurology

Latest News

FDA Finally to Discuss NurOwn’s MSC-NTF Cell Therapy for ALS
FDA Finally to Discuss NurOwn’s MSC-NTF Cell Therapy for ALS

March 27th 2023

The company's persistence in bringing NurOwn to the market amidst negative regulatory feedback has garnered an AdComm meeting.

CGTLive’s Weekly Rewind – March 24, 2023
CGTLive’s Weekly Rewind – March 24, 2023

March 24th 2023

Consensus Met on Management of Adverse Events With Sarepta's DMD Gene Therapy
Consensus Met on Management of Adverse Events With Sarepta's DMD Gene Therapy

March 24th 2023

Death Prompts CAR-NKT Cell Therapy Hold On Neuroblastoma Trial
Death Prompts CAR-NKT Cell Therapy Hold On Neuroblastoma Trial

March 23rd 2023

AMP-101 Shows Pharmacologic and Safety Promise for Neuromuscular Disorders in Preclinical Study
AMP-101 Shows Pharmacologic and Safety Promise for Neuromuscular Disorders in Preclinical Study

March 23rd 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.